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LETTERS TO THE EDITORRegarding “Hybrid repair of aortic arch dissections”
The transparency and the honesty of the report of Cochennec
and et al1 are to be commended. Unfortunately, such negative
outcomes are soon likely to be buried in the literature.
Cochennec et al performed total arch debranching via sternot-
omy in seven of 17 patients, all of them with chronic type B dissec-
tion. In the remaining 10, they performed cervical debranching,
ﬁve in the acute phase of type B dissection. All of the sternotomy
total arch debranching had immediate stenting of the type B
dissection. In the cervical debranching, four of the ﬁve chronic
dissections had delayed stenting, with ﬁve acute dissections imme-
diately stented.
The mortality of the acute dissection cervical debranching and
stenting was 60%, with retrograde type A dissections in three of
ﬁve. The mortality of chronic dissections repair via cervical or ster-
notomy debranching was 17%. Two patients died of cerebrovas-
cular accident, and one additional patient in the chronic group
had a nonfatal neurologic injury.
It is our understanding of this article that failed obliteration of
the false lumen was documented in six of the surviving 12 (50%),
with four persistent patencies (33%) after reintervention.
While 17% mortality for treatment of chronic type B dissection
with aneurysmal degeneration sounds fair, only two patients were
over the age of 75 (one died), where the use of hybrid techniques
has been shown to be superior to open arch repair techniques.2
Their data suggests that arch hybrid repairs were being applied
to patients as young as 37 years.
Open techniques in patients under 75 years in experienced
centers are lower than 17% shown here. And to add insult to
injury, only two of the three of the surviving patients have effective
treatment of their dissecting aneurysm, the remaining being left
with endoleaks.
The early reports of stent grafting in complicated acute type B
dissections were encouraging, especially compared with historic
controls of open repairs.3 As technology disseminates across the
“real world,” our impression is that while rarely reported, the inci-
dence of retrograde type A dissection has increased. When treating
a dissected arch, the leap to a full type A dissection is a very short
one. Based on our experience, and the smattering of reports as
described by Cochennec et al, the best approach to manage
a “complicated” type B dissection extending to the aortic arch
may be an open arch replacement with a frozen elephant trunk.4
The reports available in such scenarios using frozen elephant trunk
show mortalities in the 10%-30%; this is far better than the 60%.
While we remain enthusiastic on endovascular approaches, we
cannot let commercial interests, career advancement wishes, or
misplaced desires to minimize an incision push us to perform
procedures with substandard outcomes. Our fear is that a frag-
mented practice can easily lose track of what is available to treat
a given condition and only offer what is available at a given insti-
tution or geography.
In an increasingly globalized world, dissemination of knowl-
edge and expertise to beneﬁt the patients should be our ﬁrst
priority, which would allow all of us to ﬁnd the right application
of the right technology in any given scenario.
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Thank you, Dr Ugur, for those insightful comments. As you
mentioned in your comment, it is crucial to differentiate acute
from chronic (aneurysmal degeneration) complicated type B
dissections (TBAD).
In our study, the results of hybrid repair combining cervical
debranching and thoracic stent grafting for complicated acute
TBAD involving the arch were disappointing. Indeed, of ﬁve
patients, three died during the postoperative course (two of retro-
grade aortic dissections and one of aspiration pneumonia). Those
results are in contrast with recent data reporting mortality rates
of w10% after thoracic endovascular aortic repair for complicated
acute TBAD.1,2
Although we cannot draw any ﬁrm conclusion from our
limited series, our impression is that deploying a stent graft in
the curvature of a recently dissected aortic arch in zone 0 or 1
may increase the risk of retrograde aortic dissection compared
with simple stent grafting of the thoracic descending aorta.
However, there is no ideal surgical treatment for those patients
presenting with acute TBAD involving the arch and malperfusion
syndrome or impending rupture.
Regarding complicated chronic TBAD involving the arch,
given our results of hybrid repair, we now tend to choose the
frozen elephant trunk technique using E-vita Open devices
(JOTEC, Hechingen, Germany) as the ﬁrst-line treatment, when
anesthesiologists and cardiac and vascular surgeons consider the
patient can afford it. However, this strategy is based on our expe-
rience and not evidence-based. We still think that complete aortic
arch debranching is a good option in patients who have had
previous replacement of the ascending aorta because the risk of
retrograde dissection is avoided.
We agree with you that the incidence of retrograde type A
dissections might be underestimated, especially when the thoracic
stent graft is deployed in the arch. In our series, it occurred in four
of 17 patients (23%), which is, surprisingly, much higher than
previously published data.
In your comment, you stated that only two-thirds of surviving
patients have effective treatment of their dissecting aneurysm, the
remaining being left with endoleak. This is not strictly true if we
look at updated follow-up data. Among the 12 surviving patients,
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the aneurysm or false lumen, or both, in seven patients. Two had
a persistent perfusion of the false lumen at the level of the distal
segment of the stent graft, but the aneurysmal aortic segment at
risk of rupture was excluded and the diameter of the distal thoracic
aorta remained stable. One patient with a persisting type II endo-
leak has been recently treated successfully by direct Onyx injection
(Micro Therapeutics Inc, Irvine, Calif) in the aneurysmal sac. In
another patient, a type II endoleak resolved spontaneously, with
no change in aneurysm diameter. The remaining patient presented
with an asymptomatic retrograde dissection and persistent type II
endoleak. A Bentall procedure has been recently performed, with
a good result on the postoperative computed tomography scan.
Finally, at the end of this updated follow-up, the dissecting aneu-
rysm was excluded in all surviving patients.
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Regarding “Validation of three models predicting in-
hospital death in patients with an abdominal aortic
aneurysm eligible for both endovascular and open
repair”
We congratulate van Beek et al on their recently published
article that validates three risk prediction models for in-hospital
mortality following elective abdominal aortic aneurysm repair.1
Accurate risk prediction models are essential for informed consent,
clinical decision making, and risk-adjusting surgical outcome data.
Before using a risk prediction model in clinical practice, it is impor-
tant that it is robustly validated in any cohort of patients in which it
is to be used. Although two of the models assessed in the study
have previously been validated using registry data, the study by
van Beek et al represents the ﬁrst validation of all three models
using data from a randomized clinical trial.2
An interesting ﬁnding from the study is that the Vascular
Governance North West (VGNW) model outperformed the
British Aneurysm Repair (BAR) score with regard to discrimina-
tion, albeit marginally. This may be due to the fact that some
risk factor data were not available for calculation of the BAR
score.3 It may also be due to differences in the risk factors included
in the models with a history of respiratory disease and diabetes
included in the VGNW model but not in the BAR score.4
An important aspect of model performance is calibration.
Although the VGNW model and BAR score produce acceptable
Hosmer-Lemeshow test results, both models demonstrated a trend
toward underpredicting mortality in the Dutch Randomised
Endovascular Aneurysm Management (DREAM) trial cohort.
This is not surprising, as the DREAM trial was carried out from
2000 to 2003, the VGNW model was based on data from 1999
to 2009, and the BAR score was based on data from 2008 to
2011. As surgical standards and outcomes have improved overtime, it is inevitable that risk-prediction models such as the
VGNW and BAR models underpredict mortality in a historical
cohort. In turn, it is likely that risk models such as the BAR score
will tend to overpredict mortality in the future. This “calibration
drift” has been observed with cardiac surgery risk-prediction
models and means that regular model validations with recalibration
when necessary are vital.5 The combined outcome of in-hospital
and 30-day mortality used in the DREAM cohort is another
possible reason for the observed trend towards underprediction
of mortality by the VGNW and BAR scores.
We would encourage further validation studies of both the
VGNW and the BAR score and the use of both models in clinical
practice where appropriate. To facilitate easy calculation of the
BAR score, we have developed a web calculator, which is available
at www.britishaneurysmrepairscore.com, and an app is available
from both the Apple App Store and Google Play. A prospective
validation study of both the VGNW model and BAR score by
our group is currently underway.
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